Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Pharmacology|January 1, 1990
Effect of diltiazem on experimental coronary artery thrombosis in dogsW A Schumacher, B R LucchesiJournal of Cardiovascular Pharmacology|June 1, 1989
Effect of thromboxane antagonism on recanalization during streptokinase-induced thrombolysis in anesthetized monkeysW A Schumacher, C L HeranThe Journal of Pharmacology and Experimental Therapeutics|December 1, 1983
Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivityW A Schumacher, B R LucchesiThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1989
Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserveG J Grover, W A SchumacherBasic Research in Cardiology|January 1, 1989
The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemiaG J Grover, W A SchumacherThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Effect of thromboxane receptor antagonists on venous thrombosis in ratsW A Schumacher, C L HeranJournal of Cardiovascular Pharmacology|January 1, 1988
Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogsG J Grover, W A SchumacherJournal of Lipid Mediators|July 1, 1991
Thromboxane receptor activation during bronchospasm induced by platelet-activating factorW A Schumacher, T E SteinbacherJournal of the American College of Cardiology|March 15, 1990
The thromboxane receptor antagonist SQ 30,741 reduces myocardial infarct size in monkeys when given during reperfusion at a threshold dose for improving reflow during thrombolysisW A Schumacher, G J GroverEicosanoids|January 1, 1990
Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741W A Schumacher, C L Heran, M L OgletreePageof 5